Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 219-220
  • First Published: 07 April 2023

REVIEW

Review on natural killer/T-cell lymphoma

Xiaohua He,  Yan Gao,  Zhiming Li,  Huiqiang Huang, 
  • Pages: 221-229
  • First Published: 03 November 2021

ORIGINAL ARTICLES

Elevated serum IL-13 level is associated with increased Treg cells in tumor microenvironment and disease progression of diffuse large B-cell lymphoma

Xiao Li,  Mengke Liu,  Qing Shi,  Ying Fang,  Di Fu,  Zhi-xiang Shen,  Hongmei Yi,  Li Wang,  Weili Zhao, 
  • Pages: 230-238
  • First Published: 18 March 2022

Improved method to stratify lymphoma patients with risk of secondary central nervous system involvement: A multicenter retrospective analysis

Mingxiao Lang,  Youqin Feng,  Xiangrui Meng,  Jing Zhao,  Zheng Song,  Zhengzi Qian,  Lihua Qiu,  Shiyong Zhou,  Xianming Liu,  Lanfang Li,  Haiyan Yang,  Yuqin Song,  Wei Li,  Huilai Zhang, 
  • Pages: 239-247
  • First Published: 26 September 2021

Primary treatment and recent survival trends in patients with primary diffuse large B-cell lymphoma of central nervous system, 1995–2016: A population-based SEER analysis

Cui Chen,  Peng Sun,  Xiao-Qing Sun,  Shao-Yong Chen,  Hang Yang,  Yu Wang,  Zhi-Ming Li, 
  • Pages: 248-256
  • First Published: 02 September 2021

Synergistic anticancer effect of a combination of chidamide and etoposide against NK/T cell lymphoma

Wenting Song,  Zhan Chen,  Cunzhen Shi,  Yuyang Gao,  Xiaoyan Feng,  Hongwen Li,  Zhaoming Li,  Mingzhi Zhang, 
  • Pages: 257-266
  • First Published: 01 December 2021

Clinical analysis of patients with primary and secondary extranodal natural killer/T-cell lymphoma of central nervous system

Xingying Li,  Hui Yu,  Xiaorui Fu,  Lei Zhang,  Xin Li,  Ling Li,  Xinhua Wang,  Zhenchang Sun,  Xudong Zhang,  Zhaoming Li,  Jingjing Wu,  Yu Chang,  Jiaqin Yan,  Zhiyuan Zhou,  Feifei Nan,  Xiaolong Wu,  Li Tian,  Mingzhi Zhang, 
  • Pages: 267-274
  • First Published: 01 June 2021
Open Access

Efficacy of programmed cell death 1 inhibitor maintenance therapy after combined treatment with programmed cell death 1 inhibitors and anti-CD19-chimeric antigen receptor T cells in patients with relapsed/refractory diffuse large B-cell lymphoma and high tumor burden

Juan Mu,  Haobin Deng,  Cuicui Lyu,  Jijun Yuan,  Qing Li,  Jia Wang,  Yanyu Jiang,  Qi Deng,  Jichun Shen, 
  • Pages: 275-284
  • First Published: 23 February 2022

CASE REPORT

TAFRO syndrome with fatigue and abdominal distension as the first symptom: A case report

Bai Zhou,  Chao Tang,  Guiyang Chen,  Tiebin Jiang,  Xiao Shi,  Fen Wang, 
  • Pages: 285-290
  • First Published: 08 January 2022